ExLibris header image
SFX Logo
Title: Tricyclic antidepressant and metabolite levels in chronic renal failure
Source:

Clinical Pharmacology & Therapeutics [0009-9236] Lieberman, Jeffrey yr:1985


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Sandoz, M. "Metabolism of amitriptyline in patients with chronic renal failure." European Journal of Clinical Pharmacology 26.2 (1984): 227-232. Link to Full Text for this item Link to SFX for this item
2. Rosser, S. "Nortriptyline metabolism in chronic renal failure: metabolite elimination." Clinical pharmacology and therapeutics 32.3 (1982): 322-9. Link to SFX for this item
3. Pesce, A J J. "Evaluation of amitriptyline pharmacokinetics during peritoneal dialysis." Therapeutic drug monitoring (1985): 255-7. Link to SFX for this item
4. Tsai, C. "Correlation of antidepressive agents and the mortality of end-stage renal disease." Nephrology 17.4 (2012): 390-397. Link to Full Text for this item Link to SFX for this item
5. LIEBERMAN, JEFFREY A. "Tricyclic Antidepressant Drug and Metabolite Levels in Chronic Renal Failure." Annals of the New York Academy of Sciences 463.1 (1986): 304-306. Link to Full Text for this item Link to SFX for this item
6. Mellstrom, B. "Amitriptyline metabolism: relationship to polymorphic debrisoquine hydroxylation." Clinical pharmacology & therapeutics 34.4 (1983): 516-520. Link to SFX for this item
7. Sjqvist, F. "Pharmacokinetics and biological effects of nortriptyline in man." Acta pharmacologica et toxicologica 29 Suppl 3.s3 (1971): 255-280. Link to SFX for this item
8. Haanp, Maija L. "Treatment considerations for patients with neuropathic pain and other medical comorbidities." Mayo Clinic Proceedings 85.3 (2010): -25. Link to Full Text for this item Link to SFX for this item
9. Miller, A. "Gabapentin Toxicity in Renal Failure: The Importance of Dose Adjustment." Pain medicine 10.1 (2008): 190-192. Link to SFX for this item
10. Cassano P, E. "Depression and renal disease." Seminars in dialysis 18.2 (2005): 73-81. Link to Full Text for this item Link to SFX for this item
11. L, B. "Metabolism of antidepressant and neuroleptic drugs by cytochrome p450s: clinical and interethnic aspects." Clinical pharmacology and therapeutics 82.5 (2007): 606-9. Link to SFX for this item
12. Brasiliense, Leonardo B C B. "Advances and innovations in revascularization of extracranial vertebral artery." Neurosurgery 74 Suppl 1.suppl_1 (2014): -15. Link to SFX for this item
13. Zitman, F G G. "[Experiences with electroconvulsive therapy]." Nederlands tijdschrift voor geneeskunde (1991): 1669-70. Link to SFX for this item
14. Holtzman, S. "A genetic predisposition to produce low levels of IL-10 is related to depressive symptoms: a pilot study of patients with end stage renal disease." Psychosomatics 53.2 (2012): 155-161. Link to SFX for this item
15. van Dijk, S. "Short-Term Versus Long-Term Effects of Depressive Symptoms on Mortality in Patients on Dialysis." Psychosomatic medicine 74.8 (2012): 854-860. Link to SFX for this item
16. Levy, A.D. D. "Endocrine and receptor pharmacology of serotonergic anxiolytics, antipsychotics and antidepressants." Life sciences 51.2 (1992): 83-94. Link to Full Text for this item Link to SFX for this item
17. Dogukan, A. "Gabapentin-induced coma in a patient with renal failure." Hemodialysis international 10.2 (2006): 168-169. Link to Full Text for this item Link to SFX for this item
18. Bookwalter, T. "Gabapentin-induced neurologic toxicities." Pharmacotherapy 25.12 (2005): 1817-1819. Link to Full Text for this item Link to SFX for this item
19. Bertilsson, B. "Amitriptyline metabolism: association with debrisoquin hydroxylation in nonsmokers." Clinical pharmacology and therapeutics 39.4 (1986): 369-71. Link to SFX for this item
20. Kirchheiner, J. "Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response." Molecular psychiatry 9.5 (2004): 442-73. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.